Józwiak, M.; Bauer, M.; Kamysz, W.; Kleczkowska, P.
Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”. Pharmaceuticals 2025, 18, 1451.
https://doi.org/10.3390/ph18101451
AMA Style
Józwiak M, Bauer M, Kamysz W, Kleczkowska P.
Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”. Pharmaceuticals. 2025; 18(10):1451.
https://doi.org/10.3390/ph18101451
Chicago/Turabian Style
Józwiak, Michalina, Marta Bauer, Wojciech Kamysz, and Patrycja Kleczkowska.
2025. "Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”" Pharmaceuticals 18, no. 10: 1451.
https://doi.org/10.3390/ph18101451
APA Style
Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P.
(2025). Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”. Pharmaceuticals, 18(10), 1451.
https://doi.org/10.3390/ph18101451
